Skip to main navigation Skip to search Skip to main content

Lorcaserin (Belviq): A selective serotonin 5-HT2C agonist in the treatment of obesity

Research output: Contribution to journal › Comment/debate › peer-review

Original languageEnglish
Pages (from-to)525-530+534
JournalP and T
Volume38
Issue number9
StatePublished - Sep 2013

ASJC Scopus Subject Areas

  • Pharmacology (medical)

Disciplines

  • Medical Pharmacology

Cite this